Gilead Sciences GILD
NASDAQ GILD
$157.19 +3.62 (+2.36%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Land & Improvements (2010 - 2011)

Updated

Gilead Sciences (GILD) posted Land & Improvements of $149.38 million for Q4 2011, up 8.4% from $137.81 million a year earlier.

Analysis

Gilead Sciences (GILD) Land & Improvements (2010 - 2011) Analysis & Trends

  • In prior years, Gilead Sciences' Land & Improvements was $137.81 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 133.42 Bn 105.43 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 149.38 Mn
Dec 31, 2010 137.81 Mn
API Access

Gilead Sciences Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=GILD&period=max&api_key=YOUR_API_KEY